Sign in
4

Changes in Ownership

Coherus Oncology, Inc. Filed Acc 0000899243-19-022360

Chief Financial Officer sold 6,318 shares at an average $21.71 ($137,154)

  • Chief Financial Officer acquired 6,318 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Viret Jean-Frederic · Chief Financial Officer

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2019-08-21 Exercise or conversion : show line 1 in the form +6,318 $10.05 $63,496 14,831 D
2019-08-21 Sale : show line 2 in the form −260 $20.73 $5,389 14,571 D
2019-08-21 Sale : show line 3 in the form −6,058 $21.75 $131,766 8,513 D
Open-market sales · 6,318 sh · avg $21.71 · $137,154

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2019-08-21 Exercise or conversion : show line 4 in the form Stock Option (Right to Buy) −6,318 120,523 D
Loading xslF345X03/doc4.xml…